Kainova Therapeutics has dosed the first patient in Europe in its DOMISOL phase 1/2 trial of DT 7012, expanding...
Read MoreBiogen has secured US FDA approval for a high dose Spinraza regimen for spinal muscular atrophy. Viridian Therapeutics has...
Read MoreDNA Script is expanding access to its SYNTAX platform across Latin America, South Korea and Japan through new distribution...
Read MoreArvinas has reported encouraging phase 1 data for ARV-102, an investigational PROTAC degrader for Parkinson’s disease. R1 Therapeutics has...
Read MoreMHRA has approved deuruxolitinib, marketed as Leqselvi, for adults with severe alopecia areata, adding a new prescription treatment option...
Read MoreKatalyze Data and SAS have developed DementAI, a UK-built artificial intelligence system designed to help identify Alzheimer’s disease risk...
Read More